Aptamin C Miracle Maskpack
Miracle Line is the first Aptamin C skin care line product. It's contains Aptamin®C patented technology which protects vitamin C
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- Available,ODM,OEM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- antiaging, antiaging face mask, aptamin, aptamin c
- Category
- Face Mask
Product name | Aptamin C Miracle Maskpack | Certification | - |
---|---|---|---|
Category | Face Mask | Ingredients | ADENOSIN,DNA,NIACINAMIDE |
Keyword | antiaging , antiaging face mask , aptamin , aptamin c | Unit Size | 120.0 * 170.0 * mm |
Brand name | - | Unit Weigh | 29 mg |
origin | South Korea | Stock | 10000 |
Supply type | Available,ODM,OEM | HS code | - |
Product Information
Miracle Line is the first Aptamin C skin care line product. It's contains Aptamin®C patented technology which protects vitamin C, a natural antioxidant from external environments such as light and temperature, and delays oxidation.
Miracle Line helps the skin color brightening by reducing oxidized melanin, as well as containing hyaluronic acid (Deep Sea Water & Sodium Hyaluronate) to protect the skin from water loss, and also increasing the flexibility and elasticity of the skin.
After many trials with various skin specialists and cosmetics experts in Korea, it's become a popular product for its soft and moist formulation.
B2B Trade
Price (FOB) | Negotiable | transportation | Air Transportation,Express,Land Transportation,Negotiation Other,Ocean Shipping |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- Jung wook, Shim
- Address
- A2207 UTower Sinsuro 767, Suji-gu, Yongin-si, Gyeonggi-do, Korea
- Product Category
- Face Cream & Lotion,Other Personal Care,Shampoo,Skin Care Serum
- Year Established
- 2014
- Company introduction
-
Nexmos is an innovative, biotechnology R&D company with a brand new DNA meta platform protected by global intellectual properties. Founded in 2014, the company has mainly developed DNA based Aptamer technology with registered related patents and worked in the healthcare and therapeutics industry using its technology.
Nexmos believes that innovation is the key to improving humanity's life. Nexmos bioexperts are dedicated to solving degenerative brain diseases with new drugs and treatments and continually expanding more diverse industries such as skincare, F&B, etc. We are constantly striving that more people can enjoy the benefits of the DNA substance
- Main Markets
-
Hong Kong(China)
Japan
Malaysia
Thailand
U. Kingdom
U.S.A
- Main Product